Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

Program Chairs

Jonathan Barker, MD, FRCP, FRCPath
St John's Institute of Dermatology
London, England, United Kingdom
IPC President

Jonathan Barker, MD, is Professor of Medical Dermatology at St John’s Institute of Dermatology, King’s College London and honorary consultant dermatologist at Guy’s and St. Thomas’s Hospitals specializing in complex hospital based medical dermatology. He is senior consultant in the severe psoriasis service and co-director of the Skin Therapy Research Unit which conducts academic and commercially sponsored clinical studies and trials. Professor Barker is the current President of International Psoriasis Council having previously been a board member and chair of the scientific committee. He is a principal investigator in national and international consortia using genetic and multi-omic approaches to discover causal disease mechanisms, new drug targets and biomarkers of disease subtypes and outcomes to therapeutic interventions. These are being applied to important chronic skin diseases such as psoriasis, acne and eczema. Professor Barker has published over 300 peer-reviewed papers, authored and edited several books including the latest (9th) edition of Rook’s Textbook of Dermatology. Highly cited publications include those in the Lancet, Nature Genetics and New England Journal of Medicine. Professor Barker was head of department at the Institute of Dermatology 2002-2018 and course director of the Institute’s MSc Clinical Dermatology for overseas graduates. He is a past President of the European Dermatology Forum and the European Society for Dermatological Research. He is an honorary overseas member of several national dermatological associations including Denmark, France, Germany, Japan, and the USA.

Last Updated: Oct 04, 2018

Peter van de Kerkhof, MD, PhD, Chief Medical Officer
International Psoriasis Council
Amsterdam, Netherlands

Professor Peter van de Kerkhof served as head of the department Dermatology at the Radboud University Nijmegen Medical Centre, The Netherlands, since 1992 and is currently a Professor Emeritus there. He graduated in medicine from the Catholic University of Nijmegen in 1978 and trained in Dermatology at the St. Radboud Hospital, Nijmegen. In 1983 and in 1990 he completed his theses in the faculty of medicine and faculty of sciences resp. Between 1980 and 1984 he completed his training as a dermatologist. Research interests of Professor van de Kerkhof are psoriasis, disorders of keratinization, inflammation and clinical pharmacology of the skin. He has been president of major European Dermatological societies such as European Society of Dermatological Research and European Dermatology Forum. He is member of the editorial board of several international dermatological journals. He is an author or coauthor of more than 600 peer reviewed dermatological journals. He joined the IPC Staff as Chief Medical Officer in July 2018.

Last Updated: Jan 09, 2019

 

Program Faculty

Hervé Bachelez, MD, PhD
Department of Dermatology, Hôpital Saint-Louis, Imagine Institute for Human Genetic Diseases, University of Paris
Paris, France
IPC Board Member

Professor Bachelez is professor at the Department of Dermatology of the Assistance Publique-Hôpitaux de Paris Saint-Louis University Hospital in Paris, France. Since 2004, Professor Bachelez has been full professor of clinical dermatology at the Université Paris-Diderot/Université de Paris, where he received his Ph.D. in Immunology in 1999. Professor Bachelez’s clinical and research activities focus on inflammatory skin diseases, mainly psoriasis and psoriasis-related diseases, but also hidradenitis suppurativa, lichen planus among others. He is conducting his basic and translational research at the Institut National de la Santé et de la Recherche Médicale (INSERM U1163), in the Laboratory of Genetics of Skin Diseases at the Imagine Institute for Human Genetic Diseases in Necker Hospital, Paris. His areas of scientific research include immunogenetics and molecular mechanisms of the aforementioned immune-mediated and inflammatory skin diseases. Professor Bachelez has received several scientific awards, including the Robert Degos award. He is a member of several national and international scientific societies, including the European Academy of Dermatology and Venereology and the European Dermatology Forum (EDF). He is the past president of the French society for Dermatological Research and of the Group for Research on Psoriasis of the French Society for Dermatology. Internationally, he is a board member of the International Psoriasis Council, and is currently serving as General Secretary-Treasurer and President-Elect of the European Society for Dermatological Research (ESDR). Professor Bachelez has published more than 255 manuscripts in peer-reviews journals, including the New England Journal of Medicine, Journal of Clinical Investigation, the Lancet, and Arthritis and Rheumatism as leading author.

Last Updated: May 04, 2021

Christopher EM Griffiths, OBE, MD, FRCP, FMedSci
University of Manchester
Manchester, England, United Kingdom
Honorary Founder

Chris Griffiths qualified in Medicine from St Thomas’ Hospital Medical School, London and trained in Dermatology at St Mary’s Hospital, London and the University of Michigan, USA. He was appointed to the Foundation Chair in Dermatology at the University of Manchester in 1994. Chris founded the Manchester Dermatopharmacology Unit and the Manchester Psoriasis Service in 1994. In 2015 he received the Sir Archibald Gray Medal, for outstanding service to British Dermatology, and in 2019 the British Society for Investigative Dermatology Medal for contributions to research. In 2018 Chris was awarded Pro Meritis of the European Dermatology Forum (EDF) and was appointed OBE, for services to dermatology, in the Queen’s New Year Honours. He is an NIHR Emeritus Senior Investigator and a Fellow of the Academy of Medical Sciences.

Professor Griffiths is a previous President of the European Society for Dermatological Research, British Association of Dermatologists (BAD), and the International Psoriasis Council which he co-founded in 2004. Chris is: Director of the MRC stratified medicine consortium on psoriasis (Psoriasis Stratification to Optimise Relevant Therapy; PSORT); Director of the Global Psoriasis Atlas; and Chief Investigator of the BAD Biologics and Immunomodulators Register. He has 722 Pubmed cited articles (h-index 131), and is Editor-in-Chief of Rook’s Textbook of Dermatology. Chris has a career-long interest in all aspects of psoriasis and is credited with helping to develop the concept that psoriasis is an immune-mediated disease.
He runs international courses on art appreciation for clinicians and is active in global health initiatives including co-founding the Burma Skincare Initiative charity and advisor to the ILDS on global health research and policy.

Last Updated: Sep 05, 2019

Satveer Mahil, PhD, MRCP
St John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust
London, England, United Kingdom

Dr. Satveer Mahil is a Consultant Dermatologist at St John's Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust, London, UK, and adjunct Senior Lecturer at King's College London, UK.
She graduated from the University of Cambridge (Gonville and Caius College), UK and completed clinical dermatology training at St John’s Institute of Dermatology. She completed a Medical Research Council-funded Ph.D., which involved using genetic information to gain novel insights into the mechanistic basis of different forms of psoriasis and define new therapeutic targets. She has a major clinical and research interest in psoriasis. She is co-director of the PsoProtect and PsoProtectMe global registries. As director of St John’s DermAcademy, she also leads the development and delivery of dermatology educational resources for healthcare professionals.

Last Updated: Mar 02, 2021

Alexander Navarini, MD, PhD
University Hospital of Basel
Basel, Switzerland

Alexander Navarini is chairman of the Department of Dermatology, University Hospital of Basel since 2018. He was elected professor of immunodermatology, deputy head of the outpatient clinic and head of the patch testing laboratory at the University of Zurich, as well as leading the clinics for hand eczema and work-related dermatology, psoriasis and acne. Prof. Alexander Navarini graduated from medical school at the University of Basel and Université Marie-Curie in Paris, France in 2002. Between 2003 and 2006 he completed a postgraduate course in Experimental Medicine and Biology and MD Ph.D. studies at the University of Zurich. His research focuses on next generation genetics and gene hunting, as well as visual detection of skin diseases. He has published over 130 peer-reviewed articles and several bookchapters. Alexander Navarini is currently Principal Investigator of the European Rare and Severe Psoriasis Network (ERASPEN) for harmonizing phenotype descriptions, as well as of several clinical trials and the Swiss psoriasis registry.

Last Updated: Mar 26, 2019

Amy Paller, MD
Northwestern University Feinberg Medical School
Chicago, Illinois, United States

Amy Paller, MS, MD is the Walter J. Hamlin Professor and Chair of Dermatology, Professor of Pediatrics, and Principal Investigator of the NIH-funded Skin Biology and Diseases Resource-based Center at Northwestern University's Feinberg School of Medicine. She received her undergraduate and graduate degrees from Brown University and her medical degree from Stanford University. Dr. Paller completed residency training in Pediatrics and Dermatology at Northwestern University and her postdoctoral research fellowship at University of North Carolina. She is currently President of the International Society of Pediatric Dermatology and has served as President of the Society for Investigative Dermatology, the Society for Pediatric Dermatology, the International Eczema Council, the Pediatric Dermatology Research Alliance, and the Women's Dermatological Society. She has also been on the Board of many national and international organizations, including the American Board of Dermatology and has served on the editorial boards of leading journals, including the Journal of Investigative Dermatology. She has written several leading textbooks, among them the leading textbook for pediatric dermatology, Hurwitz' Clinical Pediatric Dermatology. An author of almost 550 original publications, Dr. Paller is an NIH-funded investigator who conducts both laboratory-based and clinical investigations related to psoriasis. Dr. Paller has led international epidemiological studies related to psoriasis and has developed new tools to measure patient-related outcomes, such as itch and stigma. She has been the lead investigator on landmark trials in pediatric skin disease, including the trial of the first TNF inhibitor and first IL-17 inhibitor for children with psoriasis. She has served on the Medical Advisory Board (now Emeritus) and received the Excellence in Leadership Award from the National Psoriasis Foundation. Dr. Paller has been an active IPC Councilor since 2010.

Last Updated: May 20, 2021

Bruce Strober, MD, PhD
Central Connecticut Dermatology, Cromwell, CT and Yale University, Department of Dermatology
New Haven, Connecticut, United States
IPC Secretary/Treasurer

Bruce E. Strober, MD, PhD, is a Clinical Professor at Yale University, Department of Dermatology. He received his medical and graduate degrees from Columbia University College of Physicians and Surgeons in New York, NY, and completed his postgraduate training in dermatology at New York University in New York, NY. Dr. Strober is board certified by the American Board of Dermatology, a fellow of the American Academy of Dermatology, and a past member of the medical board of the National Psoriasis Foundation.  He is the Co-Scientific Director of the Corrona Psoriasis Registry and Editor-in-Chief of the Journal of Psoriasis and Psoriatic Arthritis. Dr. Strober has authored numerous journal articles and book chapters. He has also spoken extensively to both physician and patient audiences in the field of dermatology.

Last Updated: Sep 21, 2020

Fellows

Jaquelini Barboza da Silva, MD
Santa Cruz University
Santa Cruz, Brazil
2021 Fellow

Jaquelini Barboza da Silva, MD is a dermatologist in private practice in Santa Cruz do Sul, Brazil. Additionally, Dr. Barboza da Silva is an instructor at Santa Cruz University, where she completed a master’s degree studying biomarkers in psoriasis by spectroscopy. She is a blind investigator in a rizankizumab clinical trial at Moinhos de Vento research center. Dr. Barboza da Silva has scientific interests in biomarkers and the burden of psoriasis. Her key clinical interest is to provide the best treatment for each patient profile. She will study with Darren Ashcroft and Chris Griffiths of University of Manchester.

Last Updated: Aug 18, 2021

Alvaro Gonzales-Cantero, MD, PhD
Hospital Ramón y Cajal
Madrid, Spain
2021 Fellow

Alvaro González-Cantero, MD, PhD, works as a dermatologist at the Department of Dermatology of the Ramón y Cajal University Hospital in Madrid, Spain, where he combines patient care with research. He received his PhD in psoriasis and comorbidities in 2019 at the University of Castilla la Mancha. He has special interest in increasing the knowledge of the relationship between psoriasis and atherosclerosis. He is the principal investigator for a cohort study to investigate the pathophysiological mechanisms underlying cardiovascular comorbidity in psoriasis. His research on cardiovascular comorbidities and systemic inflammation in psoriasis has been published in the Journal of the American Academy of Dermatology and Plos One and his presentations on the topic have received excellency awards on several occasions in different scientific meetings. Dr. González-Cantero studied with Joel Gelfand of the University of Pennsylvania in the United States and attended the European Academy of Dermatology and Venereology (EADV) meeting.

Last Updated: Jan 06, 2020

Lily Tumalad, MD, FPDS
Rizal Medical Center
Paranaque, Philippines
2021 Fellow

Lily Tumalad, MD, FPDS is a dermatologist with special interest in psoriasis and photodermatology. She is a consultant in two government training institutions in Manila, Philippines. She is currently head of the psoriasis center of the Department of Dermatology at Rizal Medical Center, as well as head of the phototherapy unit of the Department of Dermatology at East Avenue Medical Center. Her work is a combination of clinical practice, teaching residents, conducting lectures, and research. She was the lead consultant of the technical working group for developing the clinical pathway for psoriasis at Rizal Medical Center. Dr. Tumalad completed her dermatology residency at the University of the Philippines-Philippine General Hospital and did a photodermatology fellowship at the National Skin Centre in Singapore. She will study with Curdin Conrad of Lausanne University Hospital in Switzerland and attend the European Academy of Dermatology and Venereology (EADV) meeting.

Last Updated: Jan 06, 2020

Matthew Vesely, MD, PhD
Yale School of Medicine
New Haven, Connecticut, United States
2021 Fellow

Matthew Vesely, MD, PhD, is an Instructor in the Department of Dermatology at Yale University where he combines patient care with translational research in autoimmune skin diseases. Dr. Vesely obtained his PhD in immunology studying how the immune system detectsß and eradicate cancers. Since completing his dermatology residency in 2017, his clinical interests are centered on caring for patients with inflammatory and autoimmune skin diseases. His translational research program focuses on identifying immune inhibitory receptors to better understand the pathogenesis of chronic autoimmune skin diseases such as psoriasis. Ultimately, he hopes to develop novel therapies for these debilitating disorders by modulating T cell activation states. Dr. Vesely will study with Alice Gottlieb of the Icahn School of Medicine at Mt. Sinai in the United States and attend the American Academy of Dermatology Annual Meeting (AAD).

Last Updated: Jan 06, 2020


We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK